Compare ALT & FRPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ALT | FRPH |
|---|---|---|
| Founded | 1997 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 421.5M | 435.3M |
| IPO Year | 2005 | 1995 |
| Metric | ALT | FRPH |
|---|---|---|
| Price | $3.51 | $22.06 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $17.67 | N/A |
| AVG Volume (30 Days) | ★ 2.5M | 57.8K |
| Earning Date | 05-12-2026 | 04-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 25.37 | N/A |
| EPS | N/A | ★ 0.18 |
| Revenue | $41,000.00 | ★ $42,846,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $136.81 |
| Revenue Growth | ★ 105.00 | 2.57 |
| 52 Week Low | $2.87 | $20.53 |
| 52 Week High | $7.73 | $28.45 |
| Indicator | ALT | FRPH |
|---|---|---|
| Relative Strength Index (RSI) | 51.91 | 47.07 |
| Support Level | $3.40 | $21.93 |
| Resistance Level | $3.54 | $24.59 |
| Average True Range (ATR) | 0.17 | 0.55 |
| MACD | 0.07 | 0.07 |
| Stochastic Oscillator | 96.32 | 44.83 |
Altimmune Inc is a late clinical-stage biopharmaceutical company developing therapies for patients with serious liver diseases. The Company's key candidate, pemvidutide, is a dual-action therapy targeting both glucagon and GLP-1 receptors in a balanced 1:1 ratio in development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), alcohol use disorder (AUD), and alcohol-associated liver disease (ALD). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.
FRP Holdings Inc is a holding company engaged in various real estate businesses. The company's business segments are Leasing and management of commercial properties owned by the company (the Industrial/Commercial Segment); Leasing and management of mining royalty land owned by the company (the Mining Royalty Lands Segment); real property acquisition, entitlement, development and construction for apartment, retail, warehouse, and office buildings either alone or through joint ventures (the Development Segment); ownership, leasing and management of buildings through joint ventures (the Multifamily Segment).